US company lists on the JSE

ASP Isotopes has officially been listed on the JSE as part of its planned acquisition of South African energy company Renergen.

ASP Isotopes (ASPI) is an advanced materials company dedicated to developing technology and processes for producing isotopes for use in multiple industries.

It is listed on the Nasdaq, but its primary operations are in Pretoria, where it runs isotope enrichment facilities. The company also has operations in the US and Europe.

The company describes itself as specialising in enriching stable and radioactive isotopes for use in various industries. Its revenue is generated from selling these isotopes.

On Wednesday, 27 August, ASPI announced that the JSE has improved its listing on the stock exchange’s main board. This marks the third listing on the JSE in 2025

The company will retain its primary listing on the Nasdaq, where it has been listed since 2022. 

Since announcing its intention to list on the JSE in April 2025, ASPI has progressed the overall offering in its core business and in terms of the Renergen acquisition.

The acquisition will be by way of a scheme of arrangement, under which Renergen shareholders will receive 0.09196 new ASPI shares for each Renergen share held on the record date. 

Renergen shareholders approved the resolution relating to the approval of the scheme at its general meeting held on 10 July 2025.

ASPI CEO and chairman Paul Mann said the company’s acquisition of Renergen is an exciting step. “Both isotopes and helium are viewed by almost every Western government as critically and strategically important materials,” he said. 

“The combination of these two businesses will create a company with huge strategic value and a vital part of a fragile supply chain.”

“The combination of Renergen and ASP Isotopes aims to create a global leader in the production of critical and strategically important materials.”

This includes electronic gases such as helium, various fluorinated products and isotopically enriched gases. 

“The combination is expected to create a vertically and horizontally integrated supply chain with significant geographic and customer overlap, with substantial synergies,” Mann said. 

ASPI has also progressed its plan to spin off Quantum Leap Energy (QLE) as a separate public company.

“We believe that ASP Isotopes and QLE will be better served operating independently from each other, with separate strategic plans, business models, and capital investments,” Mann said. 

“However, there will be a number of ongoing commercial agreements between the two companies.”

Renergen’s acquisition is expected to close during the third quarter of 2025, before the spin-out of QLE, which is still expected to occur during the second half of the year.